证券代码：000009 证券简称：中国宝安 公告编号：2025-019 中国宝安集团股份有限公司第十五届董事局 第四次会议决议公告 本公司及董事局全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 一、董事局会议召开情况 1、公司第十五届董事局第四次会议的会议通知于 2025 年 6 月 4 日以电话、 书面或邮件等方式发出。 2、本次会议于 2025 年 6 月 9 日以通讯方式召开。 3、会议应参与表决董事 8 人，实际参与表决 8 人。 4、本次会议的召开符合有关法律、行政法规、部门规章、规范性文件和公 司章程的规定。 二、董事局会议审议情况 1、审议了《关于董事、监事津贴的议案》。根据《公司法》《公司章程》等 相关规定，结合公司实际及行业薪酬水平，公司拟定第十五届董事局独立董事任 期内津贴为每人每年 24 万元人民币，非独立董事任期内津贴为每人每年 18 万元 人民币（在公司领薪的非独立董事不领取津贴）；第十一届监事会监事任期内津 贴为每人每年 12 万元人民币（在公司领薪的监事不领取津贴）。 为提高决策效率，董事局提请股东大会在上述方案框架内授权公司办理购买 董监高 ...

证券代码：000009 证券简称：中国宝安 公告编号：2025-018 | | | | | | | 已质押股份 | | 未质押股份 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 本次解除 | 占本公 | 占马应 | 情况 | | 情况 | | | 股东 | 持股数量 | 持股 | 质押后质 | 司所持 | 龙总股 | | | | | | 名称 | （股） | 比例 | 押股份数 | 股份比 | | 已质押股 | 占已质 | 未质押股 | 占未质 | | | | | 量（股） | 例 | 本比例 | 份限售和 | 押股份 | 份限售和 | 押股份 | | | | | | | | 冻结数量 | 比例 | 冻结数量 | 比例 | | 中国 | 126,163,313 | 29.27% | 90,000,000 | 71.34% | 20.88% | 0 | 0% | 0 | 0% | | 宝安 | | | | | | | | | | | 合计 | 126,163,313 | 29.27% | 90,000,000 ...

Core Viewpoint - The recent penalties imposed on CITIC Securities and Guotai Junan Securities by the Shanghai Stock Exchange highlight a new type of regulatory scrutiny in the investment banking sector, emphasizing the importance of compliance and timely reporting of disciplinary actions from other exchanges [2][5][10]. Summary by Sections Penalty Details - CITIC Securities and Guotai Junan Securities were penalized for failing to report disciplinary actions from other exchanges and for providing inaccurate verification opinions regarding refinancing projects [2][5]. - The penalties require both firms to submit written rectification reports signed by key personnel, indicating a significant level of scrutiny from regulators [7][10]. Reasons for Penalties - The penalties stem from four main issues: 1. Issuing verification opinions on refinancing projects without proper disclosure of prior disciplinary actions [7]. 2. Not reporting disciplinary actions from other exchanges in a timely manner [7]. 3. Providing verification opinions that did not align with actual circumstances [7]. 4. Failing to adequately monitor factors that could affect the review process [7][8]. Compliance Recommendations - Investment banks are advised to implement three key compliance measures: 1. Immediately notify relevant parties within the firm upon receiving a penalty from any regulatory body [10][11]. 2. Ensure timely communication of the implications of penalties to all involved personnel, particularly regarding project submissions [10][11]. 3. Exercise heightened caution with small-scale rapid financing projects, ensuring compliance with the 12-month prohibition on submissions following a penalty [11][12]. Industry Implications - The penalties serve as a warning to the industry, indicating that even firms with strong compliance frameworks can face scrutiny if they do not adhere to reporting requirements [10]. - The incident underscores the need for investment banks to establish robust internal mechanisms for handling regulatory communications and compliance [10][12].

Core Viewpoint - CITIC Securities and Guotai Junan Securities have been named by the Shanghai Stock Exchange and required to submit a rectification report due to discrepancies in their refinancing project applications [5][6]. Group 1: Reasons for Penalty - Both securities firms failed to report disciplinary actions taken against them by other exchanges within the past year, which led to the issuance of inaccurate verification opinions [8][9]. - The firms did not exercise due diligence regarding matters that could affect the application of review procedures, resulting in inadequate fulfillment of their sponsorship responsibilities [8][9]. Group 2: Regulatory Implications - The penalties imposed are relatively severe, requiring a written rectification report signed by key personnel, which is uncommon for such cases [6][7]. - The requirement for a rectification report may indicate that the issues are not necessarily severe but rather highlight a rare type of violation that warrants caution [6][7]. Group 3: Recommendations for Securities Firms - Upon receiving a penalty, it is crucial for the internal teams to be promptly informed, ensuring that key personnel are aware of the situation [12]. - Firms must report any disciplinary actions to all three major exchanges in a timely manner [12]. - Projects that no longer meet requirements due to penalties should be proactively withdrawn [12].

证券代码：000009 证券简称：中国宝安 公告编号：2025-017 中国宝安集团股份有限公司 关于 2025 年 1-3 月计提资产减值准备的公告 本公司及董事局全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 一、本次计提资产减值准备情况概述 中国宝安集团股份有限公司（以下简称"公司"）根据《企业会计准则》《深 圳证券交易所股票上市规则》等相关规定的要求，为真实准确地反映公司截至 2025 年 3 月 31 日的财务状况、资产价值以及 2025 年 1-3 月的经营成果，公司 对合并范围内的各类资产进行了全面检查和减值测试。根据测试结果，2025 年 1-3 月公司需计提的资产减值准备金额为 46,675,818.82 元（未经审计确认），具 体情况如下： 单位：元 | 项 | 目 | 本期发生额（正号 表示冲回，负号表 | 本期核销金额 | 本期转销金额 | | --- | --- | --- | --- | --- | | | | 示计提损失） | | | | 应收票据减值损失 | | 245,301.82 | | | | 应收账款减值损失 | | -183,12 ...

本公司及董事局全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 二、董事局会议审议情况 1、审议通过了《中国宝安集团股份有限公司 2025 年第一季度报告》，表决 结果为：同意 9 票，反对 0 票，弃权 0 票。具体内容详见同日披露的《中国宝安 集团股份有限公司 2025 年第一季度报告》（公告编号：2025-016）。 2、审议通过了《关于制定<市值管理制度>的议案》，表决结果为：同意 9 票，反对 0 票，弃权 0 票。 中国宝安集团股份有限公司第十五届董事局 第三次会议决议公告 一、董事局会议召开情况 1、公司第十五届董事局第三次会议的会议通知于 2025 年 4 月 25 日以电话、 书面或邮件等方式发出。 2、本次会议于 2025 年 4 月 29 日以通讯方式召开。 3、会议应参与表决董事 9 人，实际参与表决 9 人。 4、本次会议的召开符合有关法律、行政法规、部门规章、规范性文件和公 司章程的规定。 证券代码：000009 证券简称：中国宝安 公告编号：2025-015 特此公告 1 三、备查文件 1、经与会董事签字并加盖董事局印章的董事局决议； 2、深交 ...

Financial Performance - The company's revenue for Q1 2025 was ¥4,863,762,622.58, a decrease of 2.72% compared to ¥4,999,751,793.71 in the same period last year[4] - Net profit attributable to shareholders increased by 138.20% to ¥168,578,339.85 from ¥70,773,244.88 year-on-year[4] - Basic and diluted earnings per share rose by 138.69% to ¥0.0654 from ¥0.0274 in the same period last year[4] - Total operating revenue for the current period is ¥4,863,763,165.21, a decrease of 2.74% from ¥5,000,063,408.45 in the previous period[19] - Net profit for the current period is ¥419,047,320.06, an increase of 51.6% compared to ¥275,970,813.74 in the previous period[20] - Earnings per share (basic and diluted) is ¥0.0654, up from ¥0.0274 in the previous period[20] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥507,217,646.54, a decline of 153.65% compared to ¥945,353,375.94 in the previous year[4] - The company’s cash and cash equivalents net increase was -¥762,240,129.90, reflecting a 180.03% decline compared to the previous year[8] - Operating cash flow for the current period is -507,217,646.54 CNY, a decrease from 945,353,375.94 CNY in the previous period[21] - The company reported a net decrease in cash and cash equivalents of -762,240,129.90 CNY, compared to an increase of 952,480,261.37 CNY in the previous period[22] - The ending balance of cash and cash equivalents is 5,845,501,574.75 CNY, down from 9,606,576,960.96 CNY in the previous period[22] Assets and Liabilities - Total assets increased by 2.70% to ¥55,229,315,416.03 from ¥53,774,802,564.92 at the end of the previous year[4] - Total liabilities rose to ¥33,054,459,322.92, compared to ¥32,058,991,536.21, marking an increase of 3.11%[18] - The company’s equity attributable to shareholders increased by 1.92% to ¥10,105,345,716.87 from ¥9,914,702,465.97 at the end of the previous year[4] - The total current assets of China Baoan Group as of March 31, 2025, amounted to CNY 30,566,638,920.33, an increase from CNY 28,907,976,276.00 at the beginning of the period, reflecting a growth of approximately 5.73%[15] - Non-current assets totaled CNY 42,000,000,000.00, with fixed assets valued at CNY 14,775,368,357.35, up from CNY 14,051,313,792.48, indicating a growth of about 5.14%[16] Investment and Income - The company’s investment income surged by 236.35% to ¥134,934,014.17 from a loss of -¥98,962,411.07 in the same period last year[7] - Other income for the current period was ¥63,109,434.91, compared to ¥54,770,057.41 in the previous period, reflecting an increase of 15.5%[19] - Investment income for the current period was ¥134,934,014.17, a significant recovery from a loss of ¥98,962,411.07 in the previous period[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 169,717[11] - The company’s goodwill remained stable at CNY 450,688,631.93, with no change reported[16] Financial Management - The company reported a significant increase in financial expenses, which rose by 84.22% to ¥145,141,247.30 due to higher borrowing costs and exchange losses[8] - The total liabilities and equity structure indicates a solid financial position, with a focus on maintaining liquidity and asset management strategies[15] Research and Development - Research and development expenses for the current period were ¥243,785,322.20, up from ¥226,555,253.64, indicating an increase of 7.6%[19] Market Strategy - The company is actively exploring market expansion opportunities and new product developments to enhance its competitive edge in the industry[15] Audit Status - The company has not undergone an audit for the first quarter report[23]

中国宝安（000009）公告，2025年第一季度营业收入48.64亿元，同比下降2.72%。净利润1.69亿元，同 比增长138.20%。 ...

贝特瑞新材料集团印尼工厂。 新华社发 4月15日，中国宝安(000009.SZ)披露了2024年年报，报告期内，公司实现营业收入202.28亿元，实现归 母净利润1.73亿元。公司拟每10股派发现金红利0.3元(含税)。 贝特瑞积极布局快充负极材料 近年来，中国宝安转型为以新材料为主的产业投资集团，以生产负极材料为主的贝特瑞是其旗下重要公 司。报告期内，贝特瑞负极材料销量突破43万吨，实现产品综合成本同比下降，整体毛利率同比提升。 据介绍，贝特瑞以印尼、摩洛哥项目为支点，强化新能源材料全球供应链韧性，构建国际市场竞争优 势，成功推进印尼年产8万吨新能源锂电池负极材料一体化项目投产，并启动印尼二期年产8万吨负极材 料产能建设，同时在摩洛哥启动年产5万吨锂离子电池正极材料项目和年产6万吨锂离子电池负极材料项 目的投资建设。 此外，贝特瑞还积极布局快充负极材料、氢能与钠离子电池材料、固态电池材料和硅基负极材料等新技 术方向，助力产品竞争力提升。 马应龙聚焦高竞争优势业务 中国宝安旗下生物医药产业公司马应龙2024年积极调整业务结构，聚焦高竞争优势业务，2024年营业总 收入达37.28亿元，同比上升18.85%；归 ...

Core Insights - China Baoan reported a significant decline in both revenue and net profit for the year 2024, with total revenue of 20.23 billion yuan, down 34.10% year-on-year, and net profit attributable to shareholders of 172.63 million yuan, down 77.18% year-on-year [1][2][3] Financial Performance - Total assets increased by 7.33% year-on-year, reaching approximately 53.77 billion yuan at the end of 2024 [2] - Net assets attributable to shareholders slightly decreased by 0.18% year-on-year, totaling approximately 9.91 billion yuan [2] - The company’s basic earnings per share dropped by 77.19% to 0.0669 yuan [2] - The weighted average return on equity fell to 1.73%, down 6.18% from the previous year [2] Business Segments - The company is transitioning to an investment group focused on new materials, with its subsidiary, BetterRay, being a key player in the production of anode materials [2][3] - BetterRay achieved a sales volume of over 430,000 tons of anode materials, with a year-on-year increase in overall gross margin [2][3] - The biopharmaceutical segment, represented by Mayinglong, reported a total revenue of 3.73 billion yuan, an increase of 18.85% year-on-year, and a net profit of 528 million yuan, up 19.14% year-on-year [3] Strategic Developments - BetterRay is enhancing its global supply chain resilience through projects in Indonesia and Morocco, including an integrated project in Indonesia with an annual capacity of 80,000 tons of lithium battery anode materials [3] - The company is also investing in new technology directions such as fast-charging anode materials, hydrogen energy, sodium-ion battery materials, solid-state battery materials, and silicon-based anode materials [3]